Endocrine Flashcards
Insulin, rapid acting
Uses?
Toxicity?
Lispro
Aspart
Glulisine
Uses = DM1, DM2, GDM (postpradial glucose control) Toxicity = hypoglycemia, rare hypersensitivity rxns
Action of insulin in general
Effect on liver? Muscle? Fat?
Bind insulin receptor (tyrosine kinase activity)
Liver = increase glucose stored as glycogen
muscle = increase glycogen, protein synthesis, and K uptake
Fat = increase TG storage
Insulin, short acting
Uses?
Regular
Uses = DM1, DM2, GDM, DKA (IV), hyperkalemia (+ glucose), stress hyperglycemia
Insulin, intermediate acting
NPH = Neutral Protamine Hagedorn
Uses = DM1, DM2, GDM
Insulin, long acting
Glargine
Detemir
Uses = DM1, DM2, GDM (basal glucose control)
Biguanides
Metformin
Metformin action and uses
Biguanide = MOA unknown
Decreases gluconeogenesis
Increases glycolysis and peripheral glucose uptake (insulin sensitivity)
Oral = first line therapy in type 2 DM
Can be used in patients without islet function
Metformin toxicity
GI upset
LACTIC ACIDOSIS = most serious adverse effect (contraindicated in RENAL FAILURE)
Sulfonylureas - first generation (2)
Toxicity?
Tolbutamide
Chlorpropamide
Disulfiram-like effects
Sulfonylureas - second generation (3)
Toxicity?
Glyburide
Glimepiride
Glipizide
Hypoglycemia
Sulfonylureas Action
Tolbutamide, Chlorpropamide
Glyburide, Glimepiride, Glipizide
Close K+ channel in B-cell membrane so cell depolarizes = triggers insulin release via increased Ca2+ influx
Sulfonylureas Uses and Toxicity (general)
Tolbutamide, Chlorpropamide
Glyburide, Glimepiride, Glipizide
Stimulate release of endogenous insulin in type 2 DM
Require some islet function, so useless in type 1 DM
Toxicity = risk of hypoglycemia increased in renal failure
Can sulfonylureas be used in type 1 DM?
NO - require some islet function as they stimulate endogenous insulin release
Risk of hypoglycemia while taking sulfonylureas is increased in which type of patients?
Renal failure
Glitazones/thiazolidinediones (2)
Pioglitazone
Rosiglitazone
Pioglitazone, Rosiglitazone
Action?
Uses?
Glitazones/thiazolidinediones
Increase insulin sensitivity in peripheral tissue (also increases levels of adiponectin)
Binds to PPAR-gamma nuclear transcription regulator (activated genes regulate FA storage and glucose metabolism)
Pioglitazone, Rosiglitazone
Toxicity?
Weight gain, edema
Hepatotoxicity, heart failure
a-glucosidase inhibitors (2)
Acarbose
Miglitol
Acarbose, Miglitol
Action?
Inhibit intestinal brush border a-glucosidases
Delayed sugar hydrolysis and glucose absorption = DECREASE postprandial hyperglycemia